Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:131-137
Published online before print November 22, 2006, doi: 10.1161/01.STR.0000252159.05702.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v39,pe65)
Right arrow All Versions of this Article:
38/1/131    most recent
01.STR.0000252159.05702.00v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiart, M.
Right arrow Articles by Berthezène, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiart, M.
Right arrow Articles by Berthezène, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Encephalitis
*MRI Scans
*Stroke
Hazardous Substances DB
*FERRIC OXIDE
*HEMATITE
Related Collections
Right arrow Animal models of human disease
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Pathology of Stroke

(Stroke. 2007;38:131.)
© 2007 American Heart Association, Inc.


Original Contributions

MRI Monitoring of Neuroinflammation in Mouse Focal Ischemia

Marlène Wiart, PhD*; Nathalie Davoust, PhD*; Jean-Baptiste Pialat, MD; Virginie Desestret, MD; Samir Moucharrafie, MD; Tae-Hee Cho, MD; Mireille Mutin, BSc; Jean-Baptiste Langlois, BSc; Olivier Beuf, PhD; Jérôme Honnorat, MD, PhD; Norbert Nighoghossian, MD, PhD Yves Berthezène, MD, PhD

From Université de Lyon, Lyon, F-69003, France; INSA de Lyon, Villeurbanne, F-69621, France; CNRS, UMR 5515, Bron, F-69677, France; Inserm, U630, Bron, F-69677; France (M.W., J.-B.P., S.M., T.-H.C., N.N., Y.B.); Université de Lyon, Lyon, F-69003, France; Experimental Neurobiology and Physiopathology, Inserm U433, University of Lyon, Faculté Laennec, Lyon, France (N.D., V.D., M.M., J.H.); Animage (J.-B.L.), Small Animal Multimodal Imaging Facility, Bat CERMEP, Bron cedex, France; and Université de Lyon, Lyon, F-69003, France; Laboratoire de RMN–Méthodologie & Instrumentation en Biophysique, UMR CNRS 5012, UCBL–ESCPE, Bat CPE, Villeurbanne cedex, France (O.B.).

Correspondence to Marlène Wiart, Creatis, UMR CNRS 5515, Inserm U630, Hopital Louis Pradel, 28 Ave du Doyen Lepine, F-69677, Bron cedex, France. E-mail wiart{at}creatis.insa-lyon.fr

Background and Purpose— A growing body of evidence suggests that inflammatory processes are involved in the pathophysiology of stroke. Phagocyte cells, involving resident microglia and infiltrating macrophages, secrete both protective and toxic molecules and thus represent a potential therapeutic target. The aim of the present study was to monitor phagocytic activity after focal cerebral ischemia in mice.

Methods— Ultrasmall superparamagnetic particles of iron oxide (USPIO) were intravenously injected after permanent middle cerebral artery occlusion and monitored by high resolution MRI for 72 hours.

Results— We here present the first MRI data showing in vivo phagocyte-labeling obtained in mice with focal cerebral ischemia. USPIO-enhanced MRI kinetic analysis disclosed an inflammatory response surrounding the ischemic lesion and in the contralateral hemisphere via the corpus callosum. The imaging data collected during the first 36 hours postinjury suggested a spread of USPIO-related signal from ipsi- to contralateral hemisphere. Imaging data correlated with histochemical analysis showing inflammation remote from the lesion and ingestion of nanoparticles by microglia/macrophages.

Conclusions— The present study shows that MR-tracking of phagocyte cells is feasible in mice, which may have critical therapeutic implications given the potential neurotoxicity of activated microglia/macrophages in central nervous system disorders.


Key Words: animal model • focal ischemia • inflammation • magnetic resonance imaging • ultrasmall superparamagnetic particles of iron oxide




This article has been cited by other articles:


Home page
StrokeHome page
A. Saleh, M. Schroeter, A. Ringelstein, H.-P. Hartung, M. Siebler, U. Modder, and S. Jander
Iron Oxide Particle-Enhanced MRI Suggests Variability of Brain Inflammation at Early Stages After Ischemic Stroke
Stroke, October 1, 2007; 38(10): 2733 - 2737.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Bendszus, C. Kleinschnitz, and G. Stoll
Iron-Enhanced MRI in Ischemic Stroke: Intravascular Trapping Versus Cellular Inflammation
Stroke, May 1, 2007; 38(5): e12 - e12.
[Full Text] [PDF]


Home page
StrokeHome page
M. Wiart, N. Davoust, V. Desestret, N. Nighoghossian, and Y. Berthezene
Response to Letter by Bendszus et al
Stroke, May 1, 2007; 38(5): e13 - e13.
[Full Text] [PDF]